ESR2 and breast neoplasm: Indeed, the frequent expression of the ERβ variant isoform, ERβ5, in ERα-negative breast tumours has recently been described (Poola et al, 2005), however, we did not have access to specific antibodies to investigate this variant isoform in our breast tumour cohort.